Live Nation Entertainment, Inc. vs Merck & Co., Inc. — how do they compare? Live Nation Entertainment, Inc. trades at $180.98 (market cap $42.09B), while Merck & Co., Inc. trades at $126.26 (market cap $307.25B). The key difference: Merck & Co., Inc. is far larger — about 7.3× Live Nation Entertainment, Inc.'s market cap, and Merck & Co., Inc. pays a 2.73% dividend while Live Nation Entertainment, Inc. pays none. Which is the better fit depends on your goals.
| LYV | MRK | |
|---|---|---|
Market Cap | $42.09B | $307.25B |
Sector | Industrials | Health |
52-Week High | $186.59 | $129.52 |
52-Week Low | $125.61 | $77.60 |
Enterprise Value | $43.59B | $350.66B |
Dividend Yield | — | 2.73% |
Signals from Pluang's Aura AI — not financial advice
Live Nation (LYV) trades at $177.83, down 1.33% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported $25.20B revenue for 2025 with a slim 0.33% net margin, while recent earnings misses have pressured sentiment. Strong cash flow from operations of $1.40B supports ongoing investments in live events, with analyst consensus overwhelmingly bullish at 88.6% buy ratings.
Outlook remains positive due to resilient live event demand and projected 2026 revenue growth to $25.60B, though risks include high valuation multiples (P/E 117.5), recent earnings misses, and sensitivity to consumer discretionary spending. The consensus price target of $201.50 suggests 13% upside potential from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →